首页 | 本学科首页   官方微博 | 高级检索  
检索        

冬虫夏草抗肿瘤及免疫调节作用的研究进展
引用本文:胡贤达,黄雪,王彪,岳颖,周菲,李春云,黄福开.冬虫夏草抗肿瘤及免疫调节作用的研究进展[J].现代药物与临床,2015,38(4):448-452.
作者姓名:胡贤达  黄雪  王彪  岳颖  周菲  李春云  黄福开
作者单位:中国藏学研究中心 北京藏医院, 北京 100029;南方医科大学 肿瘤研究所, 广东 广州 510515;中国藏学研究中心 北京藏医院, 北京 100029;中国藏学研究中心 北京藏医院, 北京 100029;中国藏学研究中心 北京藏医院, 北京 100029;中国藏学研究中心 北京藏医院, 北京 100029;中国藏学研究中心 北京藏医院, 北京 100029
基金项目:北京市中医药科技项目-“冬虫夏草抗菌肽类物质的分离鉴定及其免疫调节作用的机制研究”(JJ2013-52)
摘    要:冬虫夏草为我国传统名贵中药,具有抗肿瘤、降血脂、免疫调节、祛痰、平喘、抗心律失常、保护肝肾功能等多种药理学作用。随着对冬虫夏草免疫机制的深入研究,为其作为抗肿瘤药物提供了有力证据。综述了冬虫夏草及其活性成分对黑色素瘤、甲状腺癌、胃癌、肺癌、乳腺癌等多种肿瘤的抑制作用,主要从吞噬细胞、自然杀伤细胞、树突状细胞、B/T淋巴细胞以及促进细胞因子的分泌等几个方面探讨冬虫夏草对其免疫活性的影响。其免疫调节的作用机制主要通过T淋巴细胞介导的细胞免疫应答和B/T淋巴细胞介导的体液免疫应答。

关 键 词:冬虫夏草  免疫调节  中药  抗肿瘤
收稿时间:2014/12/30 0:00:00

Progress in studies on antitumor and immunomodulatory effect of Cordyceps sinensis
HU Xian-d,HUANG Xue,WANG Biao,YUE Ying,ZHOU Fei,LI Chun-yun and HUANG Fu-kai.Progress in studies on antitumor and immunomodulatory effect of Cordyceps sinensis[J].Drugs & Clinic,2015,38(4):448-452.
Authors:HU Xian-d  HUANG Xue  WANG Biao  YUE Ying  ZHOU Fei  LI Chun-yun and HUANG Fu-kai
Institution:Beijing Tibetan Hospital, China Tibetology Research Center, Beijing 100029, China;Cancer Institute, Southern Medical University, Guangzhou 510515, China;Beijing Tibetan Hospital, China Tibetology Research Center, Beijing 100029, China;Beijing Tibetan Hospital, China Tibetology Research Center, Beijing 100029, China;Beijing Tibetan Hospital, China Tibetology Research Center, Beijing 100029, China;Beijing Tibetan Hospital, China Tibetology Research Center, Beijing 100029, China;Beijing Tibetan Hospital, China Tibetology Research Center, Beijing 100029, China
Abstract:Cordyceps sinensis as a traditional Chinese herbal medicine, has a variety of pharmacological effects of anti-tumor, reducing blood lipid, immune regulation, eliminating phlegm, relieving asthma, anti-arrhythmic, protecting liver and kidney, and so on.With the further research of immunological mechanism, C. sinensis has been considered as a potential candidate of anti-tumor drug. In this paper, amount of experiments data and clinical trials indicated the chemical constituents from C. sinensis have the significant inhibition on a variety of tumors, such as melanoma, thyroid cancer, gastric cancer, lung cancer, breast cancer, and other tumors. The strong anti-tumor activities support the interpretation of immunoregulatory mechanism of C. sinensis, which could activate T-lymphocyte cellular immune response and B/T lymphocyte-mediated humoral immune response. Our paper summarized the immune responses of the components from C. sinensis by macrophages, nature killer cells, dendritic cells, B/T lymphocytes and cytokines.
Keywords:Cordyceps sinensis (BerK  ) Sacc    immunomodulatory  Chinese materia medica  antitumor
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号